These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1334698)

  • 1. The seven-stranded beta-barrel structure of apo-neocarzinostatin as compared to the immunoglobulin domain.
    Adjadj E; Quiniou E; Mispelter J; Favaudon V; Lhoste JM
    Biochimie; 1992; 74(9-10):853-8. PubMed ID: 1334698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.
    Izadi-Pruneyre N; Quiniou E ; Blouquit Y; Perez J; Minard P; Desmadril M; Mispelter J; Adjadj E
    Protein Sci; 2001 Nov; 10(11):2228-40. PubMed ID: 11604530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional solution structure of apo-neocarzinostatin.
    Gao X
    J Mol Biol; 1992 May; 225(1):125-35. PubMed ID: 1533878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional solution structure of apo-neocarzinostatin from Streptomyces carzinostaticus determined by NMR spectroscopy.
    Adjadj E; Quiniou E; Mispelter J; Favaudon V; Lhoste JM
    Eur J Biochem; 1992 Feb; 203(3):505-11. PubMed ID: 1531194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of apo-neocarzinostatin at 0.15-nm resolution.
    Teplyakov A; Obmolova G; Wilson K; Kuromizu K
    Eur J Biochem; 1993 Apr; 213(2):737-41. PubMed ID: 8477746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential 1H NMR assignments and secondary structure of aponeocarzinostatin in solution.
    Remerowski ML; Glaser SJ; Sieker LC; Samy TS; Drobny GP
    Biochemistry; 1990 Sep; 29(36):8401-9. PubMed ID: 2147566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution NMR structure investigation for releasing mechanism of neocarzinostatin chromophore from the holoprotein.
    Takashima H; Yoshida T; Ishino T; Hasuda K; Ohkubo T; Kobayashi Y
    J Biol Chem; 2005 Mar; 280(12):11340-6. PubMed ID: 15640161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two- and three-dimensional proton NMR studies of apo-neocarzinostatin.
    Gao XL; Burkhart W
    Biochemistry; 1991 Aug; 30(31):7730-9. PubMed ID: 1831044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential 1H NMR assignment of the complex of aponeocarzinostatin with ethidium bromide and investigation of protein-drug interactions in the chromophore binding site.
    Mohanty S; Sieker LC; Drobny GP
    Biochemistry; 1994 Sep; 33(35):10579-90. PubMed ID: 8075058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assignment of the protonated 13C resonances of apo-neocarzinostatin by 2D heteronuclear NMR spectroscopy at natural abundance.
    Lefevre C; Adjadj E; Quiniou E; Mispelter J
    J Biomol NMR; 1994 Sep; 4(5):689-702. PubMed ID: 7919954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neocarzinostatin: interaction between the antitumor-active chromophore and the carrier protein.
    Takashima H; Amiya S; Kobayashi Y
    J Biochem; 1991 Jun; 109(6):807-10. PubMed ID: 1834636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton NMR studies of apo-neocarzinostatin from Streptomyces carzinostaticus. Sequence-specific assignment and secondary structure.
    Adjadj E; Mispelter J; Quiniou E; Dimicoli JL; Favaudon V; Lhoste JM
    Eur J Biochem; 1990 Jun; 190(2):263-71. PubMed ID: 2142075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential 1H and 15N NMR assignments and secondary structure of a recombinant anti-digoxin antibody VL domain.
    Constantine KL; Goldfarb V; Wittekind M; Anthony J; Ng SC; Mueller L
    Biochemistry; 1992 Jun; 31(21):5033-43. PubMed ID: 1318076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.
    Imajo S; Ishiguro M; Tanaka T; Hirama M; Teplyakov A
    Bioorg Med Chem; 1995 Apr; 3(4):429-36. PubMed ID: 8581426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
    Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
    Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
    J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling study of the structure of the macromolecular antitumor antibiotic neocarzinostatin. Origin of the stabilization of the chromophore.
    Ishiguro M; Imajo S; Hirama M
    J Med Chem; 1991 Aug; 34(8):2366-73. PubMed ID: 1831507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key interactions in neocarzinostatin, a protein of the immunoglobulin fold family.
    Valerio-Lepiniec M; Nicaise M; Adjadj E; Minard P; Desmadril M
    Protein Eng; 2002 Nov; 15(11):861-9. PubMed ID: 12538905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of loop dynamics in the neocarzinostatin chromophore binding and release mechanisms.
    Wang B; Merz KM
    Phys Chem Chem Phys; 2010 Apr; 12(14):3443-9. PubMed ID: 20336247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure determination of telokin, the C-terminal domain of myosin light chain kinase, at 2.8 A resolution.
    Holden HM; Ito M; Hartshorne DJ; Rayment I
    J Mol Biol; 1992 Oct; 227(3):840-51. PubMed ID: 1404391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.